Sunovion to Present Data on Latuda and Novel Investigational Psychotropic SEP-363856 at the 55th Annual Meeting of the American College of Neuropsychopharmacology Sunovion to Present Data on Latuda and Novel Investigational Psychotropic SEP-363856 at the 55th Annual Meeting of the American College of Neuropsychopharmacology Sunovion Pharmaceuticals Inc. will present four research posters on Latuda and two research posters on novel investigational psychotropic SEP-363856 at the 55th Annual Meeting of the American College of Neuropsychopharmacology , being held December 4-8 in Hollywood, Florida.
Donatella and Beatrice reside in a psychiatric facility in Tuscany. They have very different life stories, but a chance to escape brings them together in an adventure that will change their lives forever and will help them realize the beauty in imperfection.
ABSTRACT: Bipolar disorder is a chronic illness that causes periodic shifts in mood through episodes of dysthymia, depression, hypomania, and mania. There are two major types of bipolar disorder: bipolar I disorder, which is characterized by the presence of at least one acute manic episode, and bipolar II disorder, which is typified by hypomania and longer depressive episodes and is sometimes misdiagnosed as major depressive disorder.
E-mail: [email protected] Considerable uncertainty exists about the defining brain changes associated with bipolar disorder . Understanding and quantifying the sources of uncertainty can help generate novel clinical hypotheses about etiology and assist in the development of biomarkers for indexing disease progression and prognosis.
Epigenetic regulation may be involved in the pathophysiology of mental disorders, such as schizophrenia and bipolar disorder, and in the pharmacological action of drugs. Characterizing the epigenetic effects of drugs is an important step to optimal treatment.